Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852592 · ClinicalTrials.gov registry record · Phase 3
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
A Phase 3 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 3
- Development phase
- 46
- Enrollment target
NCT00852592 is a Phase 3 study that has completed, run by Northwestern University. The registered enrollment target is 46 participants.
The verdict
NCT00852592, a Phase 3 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the efficacy of light therapy for bipolar depression.
Interventions
- DEVICE 7000lux broad-spectrum light
- DEVICE 50lux dim red light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-05 |
| Est. Completion | 2015-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852592
The ClinicalTrials.gov registry entry for NCT00852592 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 7000lux broad-spectrum light is the first listed.
NCT00852592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852592 about?
NCT00852592 is a clinical study titled "Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial". The purpose of this study is to understand the efficacy of light therapy for bipolar depression.
What is the current status of trial NCT00852592?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 46 participants. The study started on 2009-05. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00852592?
The interventions under investigation include: 7000lux broad-spectrum light (DEVICE), 50lux dim red light (DEVICE).
Who is sponsoring clinical trial NCT00852592?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.